Techno Trends
Worldwide advancements and breakthroughs in pharmaceutical products and technology are thoroughly covered by Techno Trends. You may stay up to date with all the most recent pharmaceutical developments (product news and technological trends) taking place throughout the world.
Abbisko Therapeutics Breakthrough CSF-1R Inhibitor, Pimicotinib (ABSK021), Receives Fast Track Designation from the U.S. FDA
Abbisko Therapeutics has recently disclosed that its CSF-1R inhibitor, pimicotinib (ABSK021), has been granted fast track designation by the U.S. Food and Drug Administration...
Bristol Myers Squibb's LPA1 Antagonist Granted FDA Breakthrough Designation for Progressive Pulmonary Fibrosis
Bristol Myers Squibb recently disclosed that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for BMS-986278, an oral antagonist targeting lysophosphatidic acid...
WuXi Biologics Achieves 6 g/L/day Novel Productivity in Pilot-Scale Continuous Process
WuXi Biologics, a leading Contract Research, Development, and Manufacturing Organization, recently achieved a significant milestone in end-to-end Drug Substance...
Cessation Therapeutics Novel CSX-1004 Receives FDA Fast Track Designation for Preventing Fentanyl Overdose
Cessation Therapeutics, a clinical-stage biotechnology company focused on advancing biologics targeting substances of abuse, announced today that the U.S. Food and Drug Administration...
University of Minnesota Medical School Team Discovers Breakthrough Drug for Rare Kidney Disorder
The University of Minnesota Medical School has spearheaded recent research that unveils promising prospects in the treatment of Focal Segmental Glomerulosclerosis...
A Groundbreaking Revelation - Inhibiting P-glycoprotein (P-GP) Targets Dormant Tumor Cells After Chemotherapy
A research team at the Medical University of Vienna has made a significant breakthrough in addressing dormant tumor cells that can survive chemotherapy. Their discovery revolves around the inhibition of a specific protein known as P-glycoprotein...
Birmingham Platelet Group Unveils Pioneering Nanobody Technology Breakthrough
Researchers from the University of Birmingham have introduced a groundbreaking development in the realm of thrombosis research. They have pioneered a novel class of antibody...
Amicus Therapeutics Launches Groundbreaking Pompe Disease Treatment
Amicus Therapeutics, has secured FDA approval for an innovative two-part therapy known as Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) 65mg capsules....
Servier's TIBSOVO® (Ivosidenib Tablets) Granted FDA Acceptance and Priority Review for Treating IDH1-Mutated Relapsed or Refractory Myelodysplastic Syndrome
Servier, a renowned player in the field of oncology dedicated to advancing patient care, has made a significant announcement....
Zai Lab Secures Breakthrough Therapy Designation for Efgartigimod Alfa Injection in CIDP Patients
Zai Lab Limited has recently secured Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) for their efgartigimod alfa injection...
